Revista: | Archives of clinical psychiatry |
Base de datos: | PERIÓDICA |
Número de sistema: | 000428718 |
Autores: | Zhou, Xue-Mei1 Hu, Mao-Rong2 Gong, Mei-Yu1 Zou, Xue-Liang1 Yu, ZHi-Min1 |
Instituciones: | 1Jiangxi Mental Health Centre, Nanchang, Jiangxi. China 2The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi. China |
Año: | 2019 |
Periodo: | Mar-Abr |
Volumen: | 46 |
Número: | 2 |
Paginación: | 33-39 |
País: | Brasil |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Analítico, descriptivo |
Resumen en inglés | To compare sex difference in metabolic effect of olanzapine versus aripiprazole on schizophrenia. Methods A twelve-week prospective open-label cohort study to compare four subgroups according to first-episode schizophrenia patients’ type of drug usage and sex: female aripiprazole (n = 11), male aripiprazole (n = 11), female olanzapine (n = 10), and male olanzapine (n = 11) for body mass index, fasting serum triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and fasting glucose. Results Aripiprazole may be associated with weight gain in female patients with low-baseline weight. Aripiprazole may have an adverse effect of weight and favorable effects of circulating glucose and lipid on female over male schizophrenia patients. The aripiprazole–induced changes in glucose and lipid may be independent of body fat storage, especially for female schizophrenia patients. Olanzapine may have adverse effects of weight, glucose and lipid profiles on female over male schizophrenic patients. Discussion Our findings fill the gap in knowledge and provide a sex-specific guidance to psychiatrist better tailoring treatment to individual sex-differential characteristics and a key clue to understand the sex-differential mechanism of antipsychotics-induced metabolic dysfunction |
Disciplinas: | Medicina |
Palabras clave: | Psiquiatría, Farmacología, Esquizofrenia, Olanzapina, Aripiprazole, Efectos metabólicos, Diferencias sexuales |
Keyword: | Psychiatry, Pharmacology, Schizophrenia, Olanzapine, Aripiprazole, Metabolic effects, Sexual differences |
Texto completo: | Texto completo (Ver HTML) |